Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
5/27/2025
Eisai's Dayvigo Receives Approval in China for Insomnia
5/27/2025
PegBio Debuts on HKEx, Raising HK$300M to Advance GLP-1 Therapies
5/27/2025
DualityBio's HER3-Targeted ADC DB-1310 Shows Promising Early Results i...
5/27/2025
Salubris Pharma's S086 Receives Chinese Approval for Hypertension Trea...
5/27/2025
RemeGen's Telitacicept Gains Approval in China
5/27/2025
Sinotau Files for HK IPO to Advance Radiopharma Innovations
5/27/2025
Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...
5/27/2025
FDA Approves China's First Homegrown Painkiller Qamzova
5/27/2025
Recce Pharma Secures Key China Patent
5/27/2025
Servier Acquires BioNova's Menin Inhibitor BN104
5/27/2025
Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...
5/27/2025
Zai Lab's ZL-1310 Shows Promising Results in Extensive-Stage SCLC
5/27/2025
Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939
5/27/2025
Henlius Reports Promising Phase 1 Results for PD-L1-Targeting ADC HLX4...
5/27/2025
CTTQ's Anlotinib Combination Shows Promise
5/27/2025
XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...
5/23/2025
Recent Executive Moves
5/23/2025
Vigene and Merz Expand Strategic Partnership Across Greater China
5/23/2025
Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...
5/23/2025
CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ
5/23/2025
3SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...
5/23/2025
Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...
5/22/2025
China Approves Hengrui's Camrelizumab-Famitinib Combo
5/22/2025
Hengrui Pharma Raises $1.27B in Hong Kong Listing
5/22/2025
InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...
5/22/2025
NMPA Approves Bayer's Eylea 8 mg for nAMD
5/22/2025
China Approves Raynovent's Onradivir for Adult Influenza A Treatment
5/22/2025
NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...
5/22/2025
CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...
5/21/2025
Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...
Page:
8
/
53
Total number of articles:
1570
:
[First]
[<<]
[6]
[7]
[8]
[9]
[10]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit